Pure Health, the largest laboratory operator in the GCC, has launched a platform for travelers from any country to book Covid-19 pre-travel tests and get it done from anywhere in the world. The new portal covers a network of 1284 accredited labs globally.
The portal lists the approved labs in each country to help passengers book the tests easily. Outbound passengers to and from any of the empanelled countries can register for the screening on the portal by entering their details such as country, city and preferred lab on the portal.
We are delighted to associate with international airlines and airport operators on this initiative, which is intended to enable people to travel safely and with peace of mind to any destination that requires a negative PCR Covid-19 status. We have facilitated the Covid-19 screening in all these countries for outgoing passengers, who can book an appointment at the listed, accredited labs that are accepted by relevant airlines and health authorities.”
Mr. Pramodh BN, Head of Commercial Operations, Pure Health
“The portal enables passengers to register and avail the service. It also enables the laboratories to update and report results in selected countries,” he added.
Pure Health has built the largest global network of laboratory partners in the world in addition to having the largest Covid-19 testing capability in the Middle East, Africa and South Asia with the capacity to perform 80,000 RT-PCR tests and 110,000 laboratory based antibody tests daily.
The company is a pioneering healthcare solutions provider and one of the largest laboratory networks in the world, with 118 labs and employing over 1000 healthcare professionals across the nation.
Earlier this year, in partnership with the UAE’s Federal Authority for Identity and Citizenship (FAIC), Pure Health launched an online portal, where passengers travelling to the UAE can register to get tested for COVID-19 in their home countries through an approved network of laboratory facilities.
Incidence and risk factors of an invasive fungal lung infection among COVID-19 patients